CytomX Therapeutics Inc. (CTMX)
NASDAQ: CTMX
· Real-Time Price · USD
2.90
0.06 (2.11%)
At close: Sep 26, 2025, 3:59 PM
2.94
1.33%
After-hours: Sep 26, 2025, 07:57 PM EDT
CytomX Therapeutics Revenue
CytomX Therapeutics reported an annual revenue of $138.1M, reflecting a 36.45% growth. For the quarter ending June 30, 2025, CytomX Therapeutics generated $18.66M in revenue.
Revenue (ttm)
138.1M
Revenue Growth
36.45%
Price / Sales Ratio
0.63
Revenue / Employee
1.16M
Employees
119
Market Cap
478.25M
Revenue Chart
History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 138.1M | +36.45% |
| Dec 31, 2023 | 101.21M | +90.38% |
| Dec 31, 2022 | 53.16M | -23.59% |
| Dec 31, 2021 | 69.57M | -30.68% |
| Dec 31, 2020 | 100.36M | +74.58% |
| Dec 31, 2019 | 57.49M | -3.38% |
| Dec 31, 2018 | 59.5M | -16.92% |
| Dec 31, 2017 | 71.62M | +376.12% |
| Dec 31, 2016 | 15.04M | +95.06% |
| Dec 31, 2015 | 7.71M | +51.90% |
| Dec 31, 2014 | 5.08M | +471.73% |
| Dec 31, 2013 | 888K | n/a |